The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Scalable production of tissue like vascularised liver organoids from human PSCs bioRxiv Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through hydroxybutyrate production: Renal Failure: Vol 47, No 1 Substance Misuse and the Kidneys: Effects of Drugs on the Kidneys